* This is a professional Version *
Metabolic alkalosis is primary increase in HCO 3 − with or without compensatory increase in P co 2 ; pH may be high or nearly normal. Common causes include prolonged vomiting, hypovolemia, diuretic use, and hypokalemia. Renal impairment of HCO 3 − excretion must be present to sustain alkalosis. Symptoms and signs in severe cases include headache, lethargy, and tetany. Diagnosis is clinical and with ABG and serum electrolyte measurement. The underlying cause is treated; oral or IV acetazolamide or HCl is sometimes indicated.
Metabolic alkalosis is HCO 3 − accumulation due to acid loss, alkali administration, intracellular shift of hydrogen ion (H + —as occurs in hypokalemia), or HCO 3 − retention. Regardless of initial cause, persistence of metabolic alkalosis indicates that the kidneys have increased their HCO 3 − reabsorption, because HCO 3 − is normally freely filtered by the kidneys and hence excreted. Volume depletion and hypokalemia are the most common stimuli for increased HCO 3 − reabsorption, but any condition that elevates aldosterone or mineralocorticoids (which enhance Na reabsorption and K and H + excretion) can elevate HCO 3 − . Thus, hypokalemia is both a cause and a frequent consequence of metabolic alkalosis. Causes are listed; the most common are volume depletion (particularly when involving loss of gastric acid and Cl from recurrent vomiting or nasogastric suction) and diuretic use ( Causes of Metabolic Alkalosis).
Causes of Metabolic Alkalosis
Metabolic alkalosis involving loss or excess secretion of Cl is termed Cl-responsive, because it typically corrects with IV administration of NaCl-containing fluid. Cl-unresponsive metabolic alkalosis does not, and it typically involves severe Mg or K deficiency or mineralocorticoid excess. The 2 forms can coexist, eg, in patients with volume overload made hypokalemic from high-dose diuretics.
Symptoms and signs of mild alkalemia are usually related to the underlying disorder. More severe alkalemia increases protein binding of ionized Ca ++ , leading to hypocalcemia and subsequent headache, lethargy, and neuromuscular excitability, sometimes with delirium, tetany, and seizures. Alkalemia also lowers threshold for anginal symptoms and arrhythmias. Concomitant hypokalemia may cause weakness.
Recognition of metabolic alkalosis and appropriate respiratory compensation is Acid-Base Disorders : Diagnosis and requires ABG and measurement of serum electrolytes (including Ca and Mg).
Common causes can often be determined by history and physical examination. If history is unrevealing and renal function is normal, urinary Cl − and K + concentrations are measured (values are not diagnostic in renal insufficiency). Urinary Cl < 20 mEq/L indicates significant renal Cl − reabsorption and hence a Cl-responsive cause (see Causes of Metabolic Alkalosis). Urinary Cl > 20 mEq/L suggests a Cl-unresponsive form.
Urinary K and presence or absence of hypertension help differentiate Cl-unresponsive alkaloses. Urinary K < 30 mEq/day signifies hypokalemia or laxative misuse. Urinary K > 30 mEq/day without hypertension suggests diuretic abuse or Bartter or Gitelman syndrome. Urinary K > 30 mEq/day with hypertension requires evaluation for hyperaldosteronism, mineralocorticoid excess, and renovascular disease. Tests typically include plasma renin activity and aldosterone and cortisol levels (see Diagnosis and see Diagnosis).
Underlying conditions are treated, with particular attention paid to correction of hypovolemia and hypokalemia.
Patients with Cl-responsive metabolic alkalosis are given 0.9% saline solution IV; infusion rate is typically 50 to 100 mL/h greater than urinary and other sensible and insensible fluid losses until urinary Cl rises to > 25 mEq/L and urinary pH normalizes after an initial rise from bicarbonaturia. Patients with Cl-unresponsive metabolic alkalosis rarely benefit from rehydration alone.
Patients with severe metabolic alkalosis (eg, pH > 7.6) sometimes require more urgent correction of serum pH. Hemofiltration or hemodialysis is an option, particularly if volume overload and renal dysfunction are present. Acetazolamide 250 to 375 mg po or IV once/day or bid increases HCO 3 − excretion but may also accelerate urinary losses of K + and phosphate (PO 4 − ); volume-overloaded patients with diuretic-induced metabolic alkalosis and those with posthypercapnic metabolic alkalosis may especially benefit.
Hydrochloric acid in a 0.1 to 0.2 normal solution IV is safe and effective but must be given through a central catheter because it is hyperosmotic and scleroses peripheral veins. Dosage is 0.1 to 0.2 mmol/kg/h. Frequent monitoring of ABG and electrolytes is needed.
Metabolic alkalosis is HCO 3 − accumulation due to acid loss, alkali administration, intracellular shift of hydrogen ion, or HCO 3 − retention.
The most common causes are volume depletion (particularly when involving loss of gastric acid and Cl from recurrent vomiting or nasogastric suction) and diuretic use.
Metabolic alkalosis involving loss or excess secretion of Cl is termed Cl-responsive
Treat the cause and give patients with Cl-responsive metabolic alkalosis 0.9% saline IV.
Cl-resistant metabolic alkalosis is due to increased aldosterone effect.
Treatment of Cl-resistant metabolic alkalosis involves the correction of hyperaldosteronism.
Drug NameSelect Trade
* This is a professional Version *